Ademi, Zanfina http://orcid.org/0000-0002-0625-3522
Ackerman, Ilana N. http://orcid.org/0000-0002-6028-1612
Zomer, Ella http://orcid.org/0000-0002-9993-4297
Liew, Danny http://orcid.org/0000-0002-0131-623X
Article History
Accepted: 29 December 2020
First Online: 11 January 2021
Declarations
:
: No funding was received for the preparation of this commentary.
: Zanfina Ademi has no conflicts of interest that are directly relevant to the content of this article. Ilana N. Ackerman declares fellowship funds from the Victorian Government. Ella Zomer reports grant support from Amgen, AstraZeneca, Pfizer and Shire, outside the submitted work. Danny Liew declares grants from Abbvie, Amgen, AstraZeneca, Bristol-Myers Squibb, Edwards Lifesciences, Pfizer and Sanofi, and past participation in advisory boards and/or receipt of honoraria from Abbvie, Amgen, Astellas, AstraZeneca, Bristol-Myers Squibb, Edwards Lifesciences, Novartis, Pfizer, Sanofi and Shire, outside the submitted work.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.
Free to read: This content has been made available to all.